Trial intelligence / Profile preview

Neoadjuvant chemoradiotherapy with capecitabine in locally advanced rectal cancer

TCTR20180516003Active, not recruiting

Sponsor
Bangabandhu Sheikh Mujib Medical University
Start
Jan 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Trial of capecitabine in rectal cancer, sponsored by Bangabandhu Sheikh Mujib Medical University. Started Jan 2017; status: active, not recruiting.

02

Drugs

capecitabine
03

Conditions

rectal cancer

Beyond the preview

Go deeper on TCTR20180516003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180516003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call